# Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support

> **NCT02631174** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 27 (actual)

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Antithrombin III

## Key facts

- **NCT ID:** NCT02631174
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631174, "Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02631174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*